RIFAMPIN FOR INJECTION USP, 600 mg*/vial, Rx Only. Mfd. for: Akorn, Inc., Lake Forest, IL 60045. NDC: 17478-151-42.

FDA recall notice · announced November 25, 2015 · Akorn

Class III FDA/FSIS Class III: use is not likely to cause adverse health consequences.

The product

RIFAMPIN FOR INJECTION USP, 600 mg*/vial, Rx Only. Mfd. for: Akorn, Inc., Lake Forest, IL 60045. NDC: 17478-151-42.

Reason for recall

Failed Impurity/Degradation Specifications: Out of Specifications result obtained for a known impurity.

Notes

Distribution: US: Nationwide
Lot/code information: Lot #: 14RIF1(A), Expiry: 9/30/2016.
Quantity: 6861 Vials
Status: Terminated
Products in this recall event:
- RIFAMPIN FOR INJECTION USP, 600 mg*/vial, Rx Only. Mfd. for: Akorn, Inc., Lake Forest, IL 60045. NDC: 17478-151-42. (D-0231-2016)

Source: U.S. Food and Drug Administration public recall data. This page reports official records and is not legal, medical, or repair advice.